Publisher
Springer Science and Business Media LLC
Subject
Critical Care and Intensive Care Medicine
Reference15 articles.
1. Ibarra-Estrada M, Kattan E, Aguilera-González P, Sandoval-Plascencia L, Rico-Jauregui U, Gómez-Partida CA, et al. Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial. Crit Care. 2023;27(1):110.
2. ProvayBlue® (methylene blue) injection, 0.5%, USP—Potential Medication Errors Associated with Improper Preparation. https://americanregent.com/media/2116/np-pb-us-0019_hcp-letter-preparation_27feb2019.pdf. Accessed 24 Oct 2023.
3. Safety Wires—Don’t dilute ProvayBlue in normal Saline. ISMP Nurse Advise ERR. Volume 15, Issue 5, May 2017. https://www.ismp.org/sites/default/files/attachments/2018-03/NurseAdviseERR201705.pdf. Accessed 24 Oct 2023.
4. Memis D, Karamanlioglu B, Yuksel M, Gemlik I, Pamukcu Z. The influence of methylene blue infusion on cytokine levels during severe sepsis. Anaesth Intensive Care. 2002;30:755–62.
5. Kirov MY, Evgenov OV, Evgenov NV, Egorina EM, Sovershaev MA, Sveinbjørnsson B, et al. Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study. Crit Care Med. 2001;29:1860–7.